Dana-Farber’s Breast Oncology Center shared on X:
“Check out our most recent Breast Cancer Research Digest-a summary of last week’s publications from select high-impact journals (July 24th – July 31st, 2026).”
This also can be interesting:
FeDeriCa: 4-Year Outcomes Support Subcutaneous HER2 Therapy
